This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

A supportive government, modern infrastructure and easily accessible patient population are helping this Asian nation become a top location for clinical trial research. South Korea, a country in ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...

At the same time, a growing trend toward the use of basket and umbrella trials has been observed. Such designs offer a ...

A pioneering study published in Science Bulletin introduces an innovative data management framework that integrates AI and blockchain technology to address critical challenges in multicenter ...

Pain reduction with linzagolix for uterine fibroids is partly explained by reduced heavy menstrual bleeding and fibroid ...

Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.

Background Acute coronary syndrome (ACS) is a global leading cause of morbidity, with residual inflammation contributing to ...

A recent analysis reveals that ellipsoidal zone-retinal pigment epithelial thickness predicts future visual loss in ...